These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 36720629)

  • 1. An evolving perspective on novel modified release drug delivery systems for inhalational therapy.
    Hye T; Moinuddin SM; Sarkar T; Nguyen T; Saha D; Ahsan F
    Expert Opin Drug Deliv; 2023 Mar; 20(3):335-348. PubMed ID: 36720629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhalation of sustained release microparticles for the targeted treatment of respiratory diseases.
    Pulivendala G; Bale S; Godugu C
    Drug Deliv Transl Res; 2020 Apr; 10(2):339-353. PubMed ID: 31872342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in controlled release pulmonary therapy.
    Salama R; Traini D; Chan HK; Young PM
    Curr Drug Deliv; 2009 Aug; 6(4):404-14. PubMed ID: 19534707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future of nanomedicines for treating respiratory diseases.
    Scherließ R
    Expert Opin Drug Deliv; 2019 Jan; 16(1):59-68. PubMed ID: 30484722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro-in vivo correlation of inhalable budesonide-loaded large porous particles for sustained treatment regimen of asthma.
    Li J; Zheng H; Qin L; Xu EY; Yang L; Zhang L; Zhang X; Fan L; Beck-Broichsitter M; Muenster U; Chen L; Zhang Y; Mao S
    Acta Biomater; 2019 Sep; 96():505-516. PubMed ID: 31265921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery strategies for sustained drug release in the lungs.
    Loira-Pastoriza C; Todoroff J; Vanbever R
    Adv Drug Deliv Rev; 2014 Aug; 75():81-91. PubMed ID: 24915637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges and advances in the development of inhalable drug formulations for cystic fibrosis lung disease.
    Ibrahim BM; Tsifansky MD; Yang Y; Yeo Y
    Expert Opin Drug Deliv; 2011 Apr; 8(4):451-66. PubMed ID: 21375469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary liposomal formulations encapsulated procaterol hydrochloride by a remote loading method achieve sustained release and extended pharmacological effects.
    Tahara K; Tomida H; Ito Y; Tachikawa S; Onodera R; Tanaka H; Tozuka Y; Takeuchi H
    Int J Pharm; 2016 May; 505(1-2):139-46. PubMed ID: 27012982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dry powder inhalers in COPD, lung inflammation and pulmonary infections.
    Muralidharan P; Hayes D; Mansour HM
    Expert Opin Drug Deliv; 2015 Jun; 12(6):947-62. PubMed ID: 25388926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nano-Strategies for Improving the Bioavailability of Inhaled Pharmaceutical Formulations.
    Xing Y; Lu P; Xue Z; Liang C; Zhang B; Kebebe D; Liu H; Liu Z
    Mini Rev Med Chem; 2020; 20(13):1258-1271. PubMed ID: 32386491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug delivery to the lungs: challenges and opportunities.
    Newman SP
    Ther Deliv; 2017 Jul; 8(8):647-661. PubMed ID: 28730933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chinese expert consensus on standardized inhaler device application in stable chronic airway diseases (2023)].
    Inhalation Therapy and Respiratory Rehabilitation Group, Respiratory Equipment Committee of China Association of Medical Equipment
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Nov; 46(11):1055-1067. PubMed ID: 37914418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newer approaches and novel drugs for inhalational therapy for pulmonary arterial hypertension.
    Keshavarz A; Kadry H; Alobaida A; Ahsan F
    Expert Opin Drug Deliv; 2020 Apr; 17(4):439-461. PubMed ID: 32070157
    [No Abstract]   [Full Text] [Related]  

  • 14. Newer devices and improved formulations of inhaled insulin.
    Rashid J; Absar S; Nahar K; Gupta N; Ahsan F
    Expert Opin Drug Deliv; 2015 Jun; 12(6):917-28. PubMed ID: 25485886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in controlled pulmonary drug delivery.
    Liang Z; Ni R; Zhou J; Mao S
    Drug Discov Today; 2015 Mar; 20(3):380-9. PubMed ID: 25281854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled Therapy in Respiratory Disease: The Complex Interplay of Pulmonary Kinetic Processes.
    Borghardt JM; Kloft C; Sharma A
    Can Respir J; 2018; 2018():2732017. PubMed ID: 30018677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of Chitosan and its Derivatives in Nanocarrier Based Pulmonary Drug Delivery Systems.
    Dua K; Bebawy M; Awasthi R; Tekade RK; Tekade M; Gupta G; De Jesus Andreoli Pinto T; Hansbro PM
    Pharm Nanotechnol; 2017; 5(4):243-249. PubMed ID: 28786352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension.
    Shahin HI; Vinjamuri BP; Mahmoud AA; Shamma RN; Mansour SM; Ammar HO; Ghorab MM; Chougule MB; Chablani L
    J Control Release; 2019 May; 302():126-139. PubMed ID: 30940497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanosize drug delivery system.
    Mukherjee B
    Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Present Situation and Future Progress of Inhaled Lung Cancer Therapy: Necessity of Inhaled Formulations with Drug Delivery Functions.
    Okuda T; Okamoto H
    Chem Pharm Bull (Tokyo); 2020; 68(7):589-602. PubMed ID: 32611996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.